Related Experiment Video

Updated: Nov 26, 2025

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.8K

Survival Factors ID'd for Patients with Blood Cancer + COVID-19

    Cancer Discovery
    |December 14, 2020
    PubMed

    Insights

    A study found that 33% of blood cancer patients hospitalized with COVID-19 died. Older age and less intensive treatment were key risk factors for mortality in these patients.

    Area of Science:

    • Hematology
    • Infectious Diseases
    • Oncology

    Background:

    • The COVID-19 pandemic has posed significant risks to vulnerable populations, including patients with hematologic malignancies.
    • Real-time data collection is crucial for understanding the impact of COVID-19 on cancer patients.

    Purpose of the Study:

    • To analyze the outcomes of patients with hematologic malignancies who contracted COVID-19.
    • To identify risk factors associated with mortality in this patient group.

    Main Methods:

    • The American Society of Hematology Research Collaborative COVID-19 Registry for Hematology was established to collect data.
    • Analysis focused on patients with blood cancers hospitalized for COVID-19.

    Main Results:

    • 33% of hospitalized patients with blood cancers and COVID-19 died.
    • Identified risk factors for mortality included older age, forgoing intensive treatment, and a poor pre-infection prognosis.

    Conclusions:

    • Patients with hematologic malignancies face a high mortality risk when hospitalized for COVID-19.
    • Proactive monitoring and tailored treatment strategies are essential for managing COVID-19 in blood cancer patients.

    More Related Videos

    Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays06:03

    Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

    Published on: September 20, 2024

    1.6K
    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery06:46

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

    Published on: September 27, 2024

    517

    Related Concept Videos

    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    533
    Factors Affecting the Risk of Infection01:26

    Factors Affecting the Risk of Infection

    The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
    The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
    13.1K
    Regulation of Hematopoietic Stem Cells01:01

    Regulation of Hematopoietic Stem Cells

    All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
    3.7K
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    9.2K
    Factors Affecting Illness01:18

    Factors Affecting Illness

    When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
    For instance, risk factors are connected to illness,...
    4.8K
    Adaptive Mechanisms in Cancer Cells02:53

    Adaptive Mechanisms in Cancer Cells

    Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
    Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
    6.3K